Inventor

Emile M. Bellott, Jr.

Inventor
Beverly, MA, US

Overview

14→
Patents
1984–2013
Patent span
Chemistry
Primary field (CPC C)

Patents· 14 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds14%
Y10TTechnical subjects covered by former us classification14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
G03FPhotomechanical production of textured or patterned surfaces, e.g. for printing, for processing of semiconductor devices4%
PatentTitleYear
8,466,286'SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors'20138,029,765'SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors'20118,008,088'SMMR (small molecule metabolite reporters) for use as in vivo glucose biosensors'20117,511,064'Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist'20097,342,038'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation'20087,060,711'Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist'20066,992,079'Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation'20066,800,658'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation'20046,534,497'Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation'20036,127,407'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation'20006,043,272'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation'20005,580,878'Substituted tryptamines phenalkylamines and related compounds'19965,403,851'Substituted tryptamines, phenalkylamines and related compounds'19954,454,200'Methods for conducting electron beam lithography'1984

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1984–2013Based in Beverly, MA, US· patent location history
1995–1996Patents assigned to INTERNEURON PHARMA (2)· patent assignee history
2003–2008Patents assigned to NUCHEM PHARMACEUTICALS INC (4)· patent assignee history
2003–2008Patents assigned to CHILDRENS MEDICAL CENTER (3)· patent assignee history
2003–2008Patents assigned to HARVARD COLLEGE (3)· patent assignee history
2006–2009Patents assigned to BIOFRONTERA BIOSCIENCE GMBH (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NUCHEM PHARMACEUTICALS INC42003–2008
CHILDRENS MEDICAL CENTER32003–2008
HARVARD COLLEGE32003–2008
BIOFRONTERA BIOSCIENCE GMBH22006–2009
INTERNEURON PHARMA21995–1996
Locations
LocationPatentsSpan
Beverly, Massachusetts, US141984–2013